等待开盘 12-12 09:30:00 美东时间
-0.090
-6.77%
今日重点评级关注:Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从8美元升至8.25美元;Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从12.5美元升至13美元
12-11 10:33
Ascendiant Capital analyst Edward Woo maintains Banzai International (NASDAQ:BNZI) with a Buy and lowers the price target from $30 to $23.
12-10 18:33
Shares of software companies are trading lower, possibly because of a rise in T...
12-02 03:07
Gainers Sagtec Global (NASDAQ:SAGT) shares moved upwards by 6.5% to $1.97 duri...
11-21 05:05
Banzai International (NASDAQ:BNZI) reported quarterly losses of $(1.64) per share which missed the analyst consensus estimate of $(0.31) by 429.03 percent. This is a 96.63 percent increase over losses of $(48.73) per
11-15 05:17
Companies Reporting Before The Bell • Inhibrx Biosciences (NASDAQ:INBX) is expe...
11-14 19:11
Banzai International, Inc. (NASDAQ: BNZI) ("Banzai" or the "Company"), a leading marketing technology company that provides essential marketing and sales solutions, today announced it has acquired the assets of
11-10 22:04
Gainers MultiSensor AI Holdings (NASDAQ:MSAI) shares rose 30.1% to $2.03 durin...
11-04 01:05
Banzai International will hold a conference call on November 14, 2025, at 4:30 p.m. ET to discuss its Q3 2025 financial results and initiatives. CEO Joe Davy and CFO Dean Ditto will lead the call, followed by a Q&A session. The webcast and presentation will be available via the investor relations section of the Company’s website. Banzai is a marketing technology company serving over 140,000 customers, offering AI-enabled solutions to target and e...
10-30 12:31
Banzai International (NASDAQ:BNZI) has reached an agreement with senior debt holder CP BF Lending to pay off and convert the remaining $4.8 million of its senior secured debt. Under the terms of the a...
10-17 20:27